From Our Partners
Saturday, June 25, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

DHS Award for Biothreat Antibody Development

by Global Biodefense Staff
July 14, 2014

The DHS Directorate of Science and Technology, Chemical and Biological Defense Division has awarded a sole source contract to Silver Lake Research Corporation (SLRC) for continued development of threat agent specific monoclonal antibodies supporting development of rapid detection assays.

SLRC has produced a group of highly specific monoclonal antibodies for use in DHS and FEDGOV assays. DHS requires that SLRC continue and complete the work for the research, development and generation of hyper-specific monoclonal antibodies specific for bacterial and viral biothreat agents.

The overall objective is to develop and deploy highly specific and sensitive rapid first responder, clinical diagnostic, and biothreat detection assays capable of fulfilling the needs of multiple agencies and departments to support the national biodefense and preparedness mission. This requirement was originally awarded to Silver Lake Research Corporation (SLRC) on June 4, 2012 under DHS Long Range Broad Agency Announcement 11-03, with several continuation contracts since that time.

“Using an innovative and proprietary EAP Immunization methods, SLRC has overcome the technical problems associated with the work that has been performed thus far under the previous and current DHS contracts to overcome the probable “non-immunogenicity” of selected sequences, and ensure that the antibodies are designed to bind to the selected sequence in the context of the intact native protein,” states the announcement.

Previously completed results from SLRC showed that of the four Bacillus anthracis antigenic marker peptides used, all four produced specific MAbs which are now being characterized by DHS, U.S. Center for Disease Control (CDC), and other Federal Research Laboratories.

“This accomplishment marks the first successful attempt to employ cytokine mediated artificial host responses, coupled with bioinformatics driven recombinant antigens as a rational approach to generating highly specific antibodies to support the development of rapid detection assays for the national biodefense and preparedness mission,” states the announcement.

From Our Partners
Tags: AnthraxAwardsBioinformaticsChemical DetectionDHS

Related Posts

Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools
Biodetection

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC